- Home
- LEXX vs IHT Comparison
LEXX vs IHT Comparison
Compare LEXX & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- IHT
- Stock Information
- Founded
- LEXX 2004
- IHT 1971
- Country
- LEXX Canada
- IHT United States
- Employees
- LEXX N/A
- IHT N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- IHT Investment Bankers/Brokers/Service
- Sector
- LEXX Health Care
- IHT Finance
- Exchange
- LEXX Nasdaq
- IHT Nasdaq
- Market Cap
- LEXX 19.6M
- IHT 20.2M
- IPO Year
- LEXX N/A
- IHT N/A
- Fundamental
- Price
- LEXX $0.83
- IHT $2.27
- Analyst Decision
- LEXX Strong Buy
- IHT
- Analyst Count
- LEXX 1
- IHT 0
- Target Price
- LEXX $7.00
- IHT N/A
- AVG Volume (30 Days)
- LEXX 146.6K
- IHT 1.6K
- Earning Date
- LEXX 07-11-2025
- IHT 07-11-2025
- Dividend Yield
- LEXX N/A
- IHT 0.89%
- EPS Growth
- LEXX N/A
- IHT N/A
- EPS
- LEXX N/A
- IHT N/A
- Revenue
- LEXX $525,923.00
- IHT $7,505,309.00
- Revenue This Year
- LEXX $0.62
- IHT N/A
- Revenue Next Year
- LEXX $14.19
- IHT N/A
- P/E Ratio
- LEXX N/A
- IHT N/A
- Revenue Growth
- LEXX 29.95
- IHT N/A
- 52 Week Low
- LEXX $0.82
- IHT $1.34
- 52 Week High
- LEXX $4.38
- IHT $2.70
- Technical
- Relative Strength Index (RSI)
- LEXX 31.77
- IHT 44.42
- Support Level
- LEXX $0.93
- IHT $2.19
- Resistance Level
- LEXX $1.05
- IHT $2.35
- Average True Range (ATR)
- LEXX 0.07
- IHT 0.08
- MACD
- LEXX -0.00
- IHT 0.00
- Stochastic Oscillator
- LEXX 14.14
- IHT 68.00
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.